Popular topics to explore
APOLLOTYRE
Operating Revenue for Q3FY26 is Rs. 7,743 Crs., 11.77% growth YoY, Total Income is Rs. 7,793 Crs., 12.35% growth YoY, Gross Profit is Rs. 3,483 Crs., 21.11% growth YoY, EBITDA is Rs. 1,186 Crs., 25.23% growth YoY, EBITDA Margin is 15.32% Improved by 165 Basis points YoY, PBT Rs. 723 Crs, 55.65% growth YoY (Contained INR 25.93 Cr. provision for New Labour Code impact), PAT Rs. 471 Crs, 39.52% growth YoY.
Highest ever quarterly revenue, both on standalone and consolidated basis.
India business: Revenue: INR 51.4 bn, 13%+ YoY, EBITDA: INR 7.5 bn, 14.5% margin, Q3 India volume growth mid-teens YoY, with double-digit growth across all categories, channel performance, margins, and branding-led pull
Europe business: Revenue: EUR 180 mn, flattish YoY (reflecting weak market), EBITDA: EUR 32 mn, 17.9% margin, muted demand, margin rebound, restructuring timeline, and mix upgrade
On QoQ basis Op. Revenue is up by 13.35%, Total Income is up by 13.58%, Gross Profit is up by 12.52%, EBITDA is up by 16.18%, PBT is up by 87.3% YoY (Due to decrease in exceptional items), and PAT is also up by 82.34%.
INR 5,800 Cr. Capex plan approved to expand PCR and TBR at the AP (Andhra Pradesh) plant, over FY27–FY29.#TrendingSectors#FundamentalViews#WatchOutFor#EquityResearch#MacroViews
9 likes·3 comments

















